Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.

Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease–human metapneumovirus (hMPV virus) and …

Track the development of Moderna’s mRNA medicines. From preclinical development to commercial phase.

Meet Moderna Moderna’s goal is to explore the potential of messenger RNA (mRNA) science to help create a new generation of medicines for patients.

You should not get mNEXSPIKE if you had a severe allergic reaction after a previous dose of either mNEXSPIKE, SPIKEVAX (COVID-19 Vaccine, mRNA), or any Moderna COVID-19 …

Join Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.

Poznaj firmę Moderna Celem firmy Moderna jest spełnienie obietnicy stworzenia nowej generacji przełomowych leków dla pacjentów z wykorzystaniem nauki o mRNA.

Learn about Moderna's Spikevax® (COVID-19 Vaccine, mRNA) 2025-2026 Formula and how it helps protect against emerging variants, following ACIP recommendation.

Our Mindsets Alongside our Values, our Mindsets allow us to overcome challenges together. We are working to build the best possible version of Moderna 20 years from now. These Mindsets …

Meet Moderna Moderna’s goal is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.